2nd Quarter - Report
MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) for FERRING PHARMACEUTICALS, INC.
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmaceutical Quality, Security, and Accountability Act S.957
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELLE DELLERSON HAYES | — |
| STEPHANIE A KENNAN New | Sr. Health Policy Advisor, Senator Ron Wyden |
| BRIAN LOOSER New | Legislative Corr. - Rep. J. Dennis Hastert |
| MONA G MOHIB New | Director, Intergov't Affairs - Dept of Labor |
| RONALD L PLATT | — |
Medical/Disease Research/Clinical Labs MED
Pharmaceutical Quality, Security, and Accountability Act S.957
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELLE DELLERSON HAYES | — |
| STEPHANIE A KENNAN New | Sr. Health Policy Advisor, Senator Ron Wyden |
| BRIAN LOOSER New | Legislative Corr. - Rep. J. Dennis Hastert |
| MONA G MOHIB New | Director, Intergov't Affairs - Dept of Labor |
| RONALD L PLATT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.